strain: C57Bl6/J
cell type: human pancreatic stellate cells
condition/treatment: primary PSCs from cancer patient
strain: C57Bl6/J
cell type: human pancreatic stellate cells
condition/treatment: primary PSCs from cancer patient
strain: C57Bl6/J
cell type: human pancreatic stellate cells
condition/treatment: primary PSCs from cancer patient
strain: C57Bl6/J
cell type: human pancreatic stellate cells
condition/treatment: primary PSCs from cancer patient
strain: C57Bl6/J
cell type: human pancreatic stellate cells
condition/treatment: primary PSCs from cancer patient
strain: C57Bl6/J
cell type: human pancreatic stellate cells
condition/treatment: primary PSCs from cancer patient
strain: C57Bl6/J
cell type: human pancreatic stellate cells
condition/treatment: primary PSCs from cancer patient
strain: C57Bl6/J
cell type: human pancreatic stellate cells
condition/treatment: primary PSCs from cancer patient
strain: C57Bl6/J
cell type: human pancreatic stellate cells
condition/treatment: primary PSCs from cancer patient
strain: C57Bl6/J
cell type: human pancreatic stellate cells
condition/treatment: primary PSCs from control patient
strain: C57Bl6/J
cell type: human pancreatic stellate cells
condition/treatment: primary PSCs from control patient
strain: C57Bl6/J
cell type: human pancreatic stellate cells
condition/treatment: primary PSCs from control patient
strain: C57Bl6/J
cell type: human pancreatic stellate cells
condition/treatment: primary PSCs from control patient
strain: C57Bl6/J
cell type: human pancreatic stellate cells
condition/treatment: primary PSCs from control patient
strain: C57Bl6/J
cell type: human pancreatic stellate cells
condition/treatment: primary PSCs from control patient
strain: C57Bl6/J
cell type: human pancreatic stellate cells
condition/treatment: primary PSCs from control patient
strain: C57Bl6/J
cell type: human pancreatic stellate cells
condition/treatment: primary PSCs from control patient
strain: C57Bl6/J
cell type: human pancreatic stellate cells
condition/treatment: primary PSCs from control patient
strain: C57Bl6/J
cell type: human pancreatic adenocarcinoma cell line
condition/treatment: DMEM
strain: C57Bl6/J
cell type: human pancreatic adenocarcinoma cell line
condition/treatment: DMEM
strain: C57Bl6/J
cell type: human pancreatic adenocarcinoma cell line
condition/treatment: 100nM calcipotriol
strain: C57Bl6/J
cell type: human pancreatic adenocarcinoma cell line
condition/treatment: 100nM calcipotriol
strain: C57Bl6/J
cell type: human pancreatic adenocarcinoma cell line
condition/treatment: conditioned media from untreated cells
strain: C57Bl6/J
cell type: human pancreatic adenocarcinoma cell line
condition/treatment: conditioned media from untreated cells
strain: C57Bl6/J
cell type: human pancreatic adenocarcinoma cell line
condition/treatment: conditioned media from calcipotriol-treated cells
strain: C57Bl6/J
cell type: human pancreatic adenocarcinoma cell line
condition/treatment: conditioned media from calcipotriol-treated cells